Efficacy of a Nucleoside-Sparing Regimen of Darunavir/Ritonavir Plus Raltegravir in Treatment-Naive HIV-1-infected Patients (ACTG A5262)
AIDS - United States
doi 10.1097/qad.0b013e32834bbaa9
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2011
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)